Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that updated phase 1 safety and efficacy data for [fam-] trastuzumab deruxtecan, an investigational HER2 targeting antibody...

Gcobisa Madlolo, an activist, a writer, a proud mother of twins and a fresh, inspiring and powerful voice for young women in her native South Africa and beyond is the recipient of the fifth...

The inaugural Global Zen Consciousness Conference (GZC) documentary production organized by Shaolin Chan Foundation (SCF) and produced by Shaolin Institute (IS) and DeRu Media (DRM) was held in...

Bayer and Loxo Oncology, Inc. (Nasdaq: LOXO), today announced updated clinical data for larotrectinib in adult and pediatric patients with TRK fusion cancer across 24 unique tumor types. The...

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced the completed stage 1 safety and efficacy data from the ongoing Phase 1b clinical trial of...